Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 300
Selected: 0
NCT IDTitle
NCT00127049Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
NCT02131480Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma
NCT01516567Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation
NCT00126269Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary
NCT00126256Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer
NCT02357953Transpulmonary Thermodilution Using an Implented Central Venous Access Port
NCT01226394Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients
NCT03244956Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer
NCT05283044Implementing Precision Medicine in cOmmunity HospiTALs
NCT06332274tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
NCT01371201First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma
NCT06828263Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate Cancer
NCT01857453Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas
NCT04746729Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy
NCT01884922Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults
NCT07591467Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer
NCT01801176Peripheral Primitive Fibromatosis
NCT05293197Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients
NCT02997384Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
NCT07532668Multicentre Retrospective Cohort Study of Palliative Care Pathways in Patients Who Died From Sarcoma
NCT01414933High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents
NCT02220049Dose Escalation of Velcade Daily Dose in Patients With Solid Tumors
NCT02666625Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank
NCT06957132Analysis of Risk Factors for Hearing Loss in Survivors of Cancer Occurred During Childhood, Adolescence or Young Adulthood
NCT05821790Role of the Tumor Microenvironment in Aggressive Meningiomas
NCT01459003Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer
NCT05119010A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma
NCT01516580Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients
NCT00412503Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents
NCT05215106Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)
NCT02246244Randomized, Double Blind, Efficacy Study of Escitalopram in ENT Cancer Patients Suffering From Emotional Distress
NCT03984318Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs
NCT03612791Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab
NCT02997358Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma
NCT06514235Image-guided Brachytherapy for Vaginal Cancer (EMBRAVE)
NCT03609112Neurocognitive Risks in Children With Solid Tumors
NCT03212651Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab
NCT05071001Long Term Brain Toxicity of Chemotherapy in Patients Treated for a Bone TumorDuring Childhood or Adolescence
NCT02673268Robot Assisted Mastectomy Via Axillary Way With Areola Conservation and Immediate Reconstruction
NCT03351296Two Chemotherapy Regimens Plus or Minus Bevacizumab
NCT02902874Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
NCT07016230Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)
NCT02992912Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours
NCT05874063Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
NCT02516995Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer
NCT07591493Adjuvant Trial in Pancreatic Neuroendocrine Tumors
NCT06902883Study on the Effectiveness and Comfort of Innovative Solutions for the Internal Transport of Patients in Wheelchairs in a Hospital Setting
NCT01211938Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract
NCT01626638Confocal Micro-endoscopy in Head and Neck Cancer/Micro Endoscopie Confocale (MEC)Oto-Rhino-Laryngologie (ORL)
NCT00407433Clinical Studies of Gemcitabine-Oxaliplatin